43 results on '"Baawuah, Frances"'
Search Results
2. Immunological imprinting of humoral immunity to SARS-CoV-2 in children
Catalog
Books, media, physical & digital resources
3. National and regional prevalence of SARS-CoV-2 antibodies in primary and secondary school children in England: the School Infection Survey, a national open cohort study, November 2021SARS-CoV-2 antibody prevalence in school children
4. Antibody Persistence After Primary SARS-CoV-2 Infection and Protection Against Future Variants Including Omicron in Adolescents: National, Prospective Cohort Study
5. Epidemiology of SARS-CoV-2 infection among staff and students in a cohort of English primary and secondary schools during 2020–2021
6. Parents’ and teachers’ attitudes to and experiences of the implementation of COVID-19 preventive measures in primary and secondary schools following reopening of schools in autumn 2020: a descriptive cross-sectional survey
7. Perceptions of adolescents on the COVID-19 pandemic and returning to school: qualitative questionnaire survey, September 2020, England
8. Immunological imprinting of humoral immunity to SARS-CoV-2 in children
9. mRNA or ChAd0x1 COVID-19 Vaccination of Adolescents Induces Robust Antibody and Cellular Responses With Continued Recognition of Omicron Following mRNA-1273
10. Emergence of the delta variant and risk of SARS-CoV-2 infection in secondary school students and staff: Prospective surveillance in 18 schools, England
11. SARS Antibody Testing in Children: Development of Oral Fluid Assays for IgG Measurements
12. Serological responses and six-month trajectories to COVID-19 Comirnaty and Spikevax booster vaccine, September 2021 to January 2022, London, United Kingdom
13. Secondary attack rates in primary and secondary school bubbles following a confirmed case: Active, prospective national surveillance, November to December 2020, England
14. Author Correction: Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England
15. Serological responses to COVID-19 Comirnaty booster vaccine, London, United Kingdom, September to December 2021
16. Antibody Persistence after Primary Sars-Cov-2 Infection and Protection Against Future Variants Including Omicron in Adolescents: National, Prospective Cohort Study
17. Children develop robust and sustained cross-reactive spike-specific immune responses to SARS-CoV-2 infection
18. Emergence of the Delta Variant and risk of SARS-CoV-2 infection in secondary school students and staff: prospective surveillance in 18 schools, England
19. Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England
20. Serological responses to COVID-19 booster vaccine in England
21. mRNA COVID-19 vaccines induce enhanced antibody and cellular responses compared to ChAdOx1 or natural infection in children
22. Antibody persistence and neutralising activity in primary school students and staff: Prospective active surveillance, June to December 2020, England
23. Emergence of SARS-CoV-2 Alpha (B.1.1.7) variant, infection rates, antibody seroconversion and seroprevalence rates in secondary school students and staff: Active prospective surveillance, December 2020 to March 2021, England
24. Feasibility and acceptability of SARS-CoV-2 testing and surveillance in primary school children in England: Prospective, cross-sectional study
25. Higher serological responses and increased vaccine effectiveness demonstrate the value of extended vaccine schedules in combatting COVID-19 in England
26. Emergence of SARS-CoV-2 Alpha (B.1.1.7) variant, infection rates, antibody seroconversion and seroprevalence rates in secondary school students and staff: active prospective surveillance, December 2020 to March 2021, England
27. Antibody persistence and neutralising activity in primary school students and staff: prospective active surveillance, June to December 2020, England
28. SARS-CoV-2 IgG detection in human oral fluids
29. SARS-CoV-2 infection, antibody positivity and seroconversion rates in staff and students following full reopening of secondary schools in England: A prospective cohort study, September–December 2020
30. Seroprevalence of SARS-CoV-2 antibodies in university students: Cross-sectional study, December 2020, England
31. Implementation of COVID-19 Preventive Measures in Primary and Secondary Schools Following Reopening of Schools in Autumn 2020; A Cross-Sectional Study of Parents’ and Teachers’ Experiences in England
32. SARS-CoV-2 infection and transmission in primary schools in England in June–December, 2020 (sKIDs): an active, prospective surveillance study
33. Children develop robust and sustained cross-reactive spike-specific immune responses following SARS-CoV-2 infection
34. Implementation of preventive measures to prevent COVID-19: a national study of English primary schools in summer 2020
35. Robust antibody responses in 70–80-year-olds 3 weeks after the first or second doses of Pfizer/BioNTech COVID-19 vaccine, United Kingdom, January to February 2021
36. Feasibility and Acceptability of SARS-CoV-2 Testing and Surveillance in Primary School Children in England
37. Robust Antibody Responses in 70-80 Year Olds following 1 or 2 Doses of Pfizer COVID-19 Vaccine
38. Prospective Active National Surveillance of Preschools and Primary Schools for SARS-CoV-2 Infection and Transmission in England, June 2020: (sKIDs: COVID-19 Surveillance in School KIDs)
39. Perceptions of Adolescents on the COVID-19 Pandemic and Returning to School: Qualitative Questionnaire Survey, England 2020
40. Seroprevalence of SARS-CoV-2 Antibodies in University Students: Cross-sectional Study, December 2020, England
41. Secondary Attack Rates in Primary and Secondary School Bubbles Following a Confirmed Case: Active, Prospective National Surveillance, November to December 2020, England
42. COVID-19 and SARS-CoV-2 Seropositivity in Children of Healthcare Workers in London
43. Managing hypertension in general practice: a cross-sectional study of treatment and ethnicity
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.